Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/7/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Olivier Boss?

Olivier Boss

Chief Scientific Officer and Founder

Energesis Pharmaceuticals

HQ Phone:  (617) 959-2322

Direct Phone: (617) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Energesis Pharmaceuticals

One Kendall Square Bldg 200, Suite 2203

Cambridge, Massachusetts,02139

United States

Company Description

Energesis Pharmaceuticals is developing therapeutics for diabetes, obesity, and lipid disorders by targeting brown adipose tissue (BAT). The Company's approach is a novel strategy leveraging recent scientific insights in BAT biology to increase the body's abil... more

Find other employees at this company (5)

Background Information

Employment History

Scientific Director

AdipoGenix , Inc.


Senior Research Investigator

Novartis Institutes for BioMedical Research Inc


Position, Key Research and Development Positions

Sirtris Pharmaceuticals , Inc.


Web References(18 Total References)


Energesis Pharmaceuticals | Our Team

energesispharma.com [cached]

Olivier Boss, PhD
Chief Scientific Officer, Founder Dr. Boss is an expert in energy metabolism and mitochondria, and has broad experience in various industry roles, most recently in key R&D positions at Sirtris (acquired by GlaxoSmithKline) and Adipogenix. Previously, he served as head of a target discovery/validation group for diabetes and obesity, and led a major program on mitochondrial bioenergetics at Novartis. Prior to this Dr. Boss discovered Energesis' brown adipocyte progenitor cells in skeletal muscle as well as the novel thermogenic mitochondrial uncoupling proteins UCP2 and UCP3. He has more than 50 publications in peer-reviewed journals, and his report on the discovery of UCP2 and 3 has become one of the most frequently cited papers in physiology. He also edited a book on the Pharmacotherapy of Obesity (CRC Press) and has several issued and pending patents. Dr. Boss performed his post-doctoral training at Harvard Medical School with Dr. Brad Lowell and working in close association with the laboratory of Bruce Spiegelman.


Energesis Pharmaceuticals | Our Team

www.energesispharma.com [cached]

Olivier Boss, PhD
Chief Scientific Officer, Founder Dr. Boss is an expert in energy metabolism and mitochondria, and has broad experience in various industry roles, most recently in key R&D positions at Sirtris (acquired by GlaxoSmithKline) and Adipogenix. Previously, he served as head of a target discovery/validation group for diabetes and obesity, and led a major program on mitochondrial bioenergetics at Novartis. Prior to this Dr. Boss discovered Energesis' brown adipocyte progenitor cells in skeletal muscle as well as the novel thermogenic mitochondrial uncoupling proteins UCP2 and UCP3. He has more than 50 publications in peer-reviewed journals, and his report on the discovery of UCP2 and 3 has become one of the most frequently cited papers in physiology. He also edited a book on the Pharmacotherapy of Obesity (CRC Press) and has several issued and pending patents. Dr. Boss performed his post-doctoral training at Harvard Medical School with Dr. Brad Lowell and working in close association with the laboratory of Bruce Spiegelman.


Haberman Associates | Obesity therapeutics revisited

biopharmconsortium.com [cached]

Energesis was confounded by Olivier Boss, PhD (formerly of Sirtris Pharmaceuticals), Brian Freeman, MD (former Venture Partner at GreatPoint Ventures), and Jean-Paul Giacobino, MD (Professor Emeritus, University of Geneva Medical School, Switzerland).
Dr. Boss serves as Energesis' Chief Scientific Officer, and Dr. Freeman as its Chief Operating Officer. Olivier Boss Olivier Boss Thank you very much for your comment, Olivier!


www.biopharmconsortium.com

Energesis was confounded by Olivier Boss, PhD (formerly of Sirtris Pharmaceuticals), Brian Freeman, MD (former Venture Partner at GreatPoint Ventures), and Jean-Paul Giacobino, MD (Professor Emeritus, University of Geneva Medical School, Switzerland).
Dr. Boss serves as Energesis' Chief Scientific Officer, and Dr. Freeman as its Chief Operating Officer.


www.masshightech.com

David Bolinsky of Xvivx, left, talks with Olivier Boss of Energesis Pharmaceuticals


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory